roundhill glp-1 & weight loss etf OZEM: Active Management Crucial in the Drug Landscape Roundhill GLP-1 & Weight Loss

Tang H, Shao H, Shaaban CE et al (2023) Newer glucose-lowering drugs and risk of dementia: a systematic review and meta-analysis of observational studies

In clinical studies, people using GLP-1 medications (especially at higher, weight-loss-approved doses like Wegovy) lost 1520% of their body weight on average over a year, alongside diet and lifestyle changes

CI poses a significant burden on older patients diagnosed with type-2 diabetes, substantially impacting their quality of life and overall health outcomes [1, 2]

However, there is not enough known about which subgroups of patients would receive the most benefit from these medications